First Time Loading...

Vanda Pharmaceuticals Inc
NASDAQ:VNDA

Watchlist Manager
Vanda Pharmaceuticals Inc Logo
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Watchlist
Price: 4.82 USD 4.33% Market Closed
Updated: Apr 30, 2024

Vanda Pharmaceuticals Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vanda Pharmaceuticals Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Revenue
$192.6m
CAGR 3-Years
-8%
CAGR 5-Years
0%
CAGR 10-Years
19%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Vanda Pharmaceuticals Inc
Revenue Breakdown

Breakdown by Geography
Vanda Pharmaceuticals Inc

Not Available

Breakdown by Segments
Vanda Pharmaceuticals Inc

Total Revenue: 192.6m USD
100%
Hetlioz: 100.2m USD
52%
Fanapt: 90.9m USD
47.2%

See Also

What is Vanda Pharmaceuticals Inc's Revenue?
Revenue
192.6m USD

Based on the financial report for Dec 31, 2023, Vanda Pharmaceuticals Inc's Revenue amounts to 192.6m USD.

What is Vanda Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
19%

Over the last year, the Revenue growth was -24%. The average annual Revenue growth rates for Vanda Pharmaceuticals Inc have been -8% over the past three years , and 19% over the past ten years .